Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy‐induced nausea and vomiting: A prospective cohort study

Chemotherapy‐induced nausea and vomiting (CINV) is an unbearable side effect. Identifying high emetic risk patients and providing more active antiemetics strategies are mandatory to improve the tolerability of chemotherapy. In this prospective cohort study, leptin, ghrelin, and substance P were meas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Park, Hyung Soon, Won, Hye Sung, An, Ho Jung, Cho, Sung Shim, Kim, Hyun Ho, Sun, Der Sheng, Ko, Yoon Ho, Shim, Byoung Yong
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7897939/
https://ncbi.nlm.nih.gov/pubmed/33369184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3693
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares